Kailera Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Waltham, Massachusetts and currently employs 145 full-time employees. The company went IPO on 2026-04-17. Kailera Therapeutics Inc is a United States-based company. The firm is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity and related conditions. Its pipeline consists of clinical- and preclinical-stage programs with injectable peptides, oral peptides, and an oral small molecule.

Industry: Pharmaceutical Preparations